Your browser doesn't support javascript.
loading
Prebiotic to Improve Calcium Absorption in Postmenopausal Women After Gastric Bypass: A Randomized Controlled Trial.
Wu, Karin C; Cao, Sisi; Weaver, Connie M; King, Nicole J; Patel, Sheena; Kingman, Hillary; Sellmeyer, Deborah E; McCauley, Kathryn; Li, Danny; Lynch, Susan V; Kim, Tiffany Y; Black, Dennis M; Shafer, Martin M; Özçam, Mustafa; Lin, Din L; Rogers, Stanley J; Stewart, Lygia; Carter, Jonathan T; Posselt, Andrew M; Schafer, Anne L.
Afiliação
  • Wu KC; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Cao S; Endocrine Research Unit, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, USA.
  • Weaver CM; Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
  • King NJ; Department of Human Sciences, the Ohio State University, Columbus, OH 43210, USA.
  • Patel S; Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
  • Kingman H; Endocrine Research Unit, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, USA.
  • Sellmeyer DE; California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA.
  • McCauley K; Endocrine Research Unit, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, USA.
  • Li D; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
  • Lynch SV; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Kim TY; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Black DM; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Shafer MM; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Özçam M; Endocrine Research Unit, San Francisco Veterans Affairs Health Care System, San Francisco, CA 94121, USA.
  • Lin DL; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA 94143, USA.
  • Rogers SJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
  • Stewart L; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Carter JT; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
  • Posselt AM; Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
  • Schafer AL; Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
J Clin Endocrinol Metab ; 107(4): 1053-1064, 2022 03 24.
Article em En | MEDLINE | ID: mdl-34888663
CONTEXT: The adverse skeletal effects of Roux-en-Y gastric bypass (RYGB) are partly caused by intestinal calcium absorption decline. Prebiotics, such as soluble corn fiber (SCF), augment colonic calcium absorption in healthy individuals. OBJECTIVE: We tested the effects of SCF on fractional calcium absorption (FCA), biochemical parameters, and the fecal microbiome in a post-RYGB population. METHODS: Randomized, double-blind, placebo-controlled trial of 20 postmenopausal women with history of RYGB a mean 5 years prior; a 2-month course of 20 g/day SCF or maltodextrin placebo was taken orally. The main outcome measure was between-group difference in absolute change in FCA (primary outcome) and was measured with a gold standard dual stable isotope method. Other measures included tolerability, adherence, serum calciotropic hormones and bone turnover markers, and fecal microbial composition via 16S rRNA gene sequencing. RESULTS: Mean FCA ± SD at baseline was low at 5.5 ± 5.1%. Comparing SCF to placebo, there was no between-group difference in mean (95% CI) change in FCA (+3.4 [-6.7, +13.6]%), nor in calciotropic hormones or bone turnover markers. The SCF group had a wider variation in FCA change than placebo (SD 13.4% vs 7.0%). Those with greater change in microbial composition following SCF treatment had greater increase in FCA (r2 = 0.72, P = 0.05). SCF adherence was high, and gastrointestinal symptoms were similar between groups. CONCLUSION: No between-group differences were observed in changes in FCA or calciotropic hormones, but wide CIs suggest a variable impact of SCF that may be due to the degree of gut microbiome alteration. Daily SCF consumption was well tolerated. Larger and longer-term studies are warranted.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Derivação Gástrica Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Derivação Gástrica Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos